Maria Companioni, DNP, APRN-BC

Chief Executive Officer & Founder | Next Phase Research 

Dr. Maria Companioni is a driving force in psychiatric and neuromodulation research, with over 100 CNS and vaccine trials executed under her leadership. With a Doctorate in Nursing Practice and dual board certification, she brings deep clinical expertise and operational command to every phase of trial execution.

As CEO of Next Phase Research and Clinical Director of Neuromodulation at My TMS, she has led innovation in patient recruitment, mapping, and protocol adherence across schizophrenia, MDD, bipolar disorder, autism, suicidality, and neurodegenerative conditions. Her work is known for translating patient care precision into high quality, sponsor ready data.
 
Together with Dr. Peter Ventre and Dr. Howard Schwartz, Dr. Companioni is shaping a forward focused clinical research team grounded in speed, scientific rigor, and reliability. Her contributions have been featured at ASCP, ISCTM, and CNS Summit, reflecting her commitment to advancing measurement-based care and collaborative research.

Dr. Peter Ventre

Chief Psychiatric Officer & Founder | Next Phase Research 

Dr. Peter Ventre stands at the forefront of psychiatric clinical research in Florida. As a board-certified psychiatrist and seasoned Principal Investigator, Dr. Ventre has led hundreds of Phase I–IV trials in schizophrenia, bipolar disorder, MDD, ADHD, Alzheimer’s, and treatment-resistant depression. His two decades of experience in CNS research have shaped some of the most impactful studies in the field.

As CEO of My Psychiatrist, one of South Florida’s most influential psychiatric practices Dr. Ventre has built a powerful bridge between real world clinical care and cutting-edge research. Today, he serves as Cofounder and Chief Psychiatric Officer of Next Phase Research, working in close collaboration with Dr. Howard Schwartz, and Dr. Maria Companioni to establish a sponsor ready ecosystem focused on scientific integrity, executional excellence, and speed.
 
With a proven track record contributing to multiple FDA approvals, Dr. Ventre continues to be a trusted partner for sponsors and CROs seeking rapid startup, reliable patient populations, and high-quality data. His leadership brings together innovation, integration, and compassion delivering research that advances both science and care.

Dr. Howard I. Schwartz

Chief Medical Officer & Founder | Next Phase Research

Dr. Howard I. Schwartz is a pioneer in CNS clinical research with more than 1,000 Phase I–IV trials led across psychiatry, neurology, and vaccines. Board-certified in Internal Medicine and Gastroenterology, he has translated decades of clinical precision into a leadership role advancing Florida’s psychiatric research landscape.

As a founding partner at Next Phase Research, Dr. Schwartz is part of a unified team alongside Dr. Peter Ventre, and Dr. Maria Companioni, driving operational excellence and scientific advancement in high impact, multi-site trials. His work spans early phase innovation, rare populations, and pivotal studies, making him a valued partner for CROs and sponsors aiming to accelerate development without sacrificing quality.
 
With a deep history in advisory, DSMB participation, and medical monitoring, Dr. Schwartz is passionate to work with pharmaceutical, Biotech and CRO sponsors on projects that require significant medical oversight and early proof of concept trials. Dr. Schwartz brings strategic clarity and regulatory foresight to every trial. For sponsors looking to re-enter Florida’s trial market with a seasoned, high-performing site network. Dr. Schwartz and the Next Phase team offer proven experience and trusted execution.

Transforming the Future of Medicine


Contributing to the development of new medications by conducting trials at the highest ethical standards.

Our Commitment

Mission and Vision of Next Phase Research

Our Mission Statement

Driven by decades of clinical research excellence, we are dedicated to shaping the future of medicine. By combining proven expertise, innovative technology, and compassionate, patient-centered care, we support the discovery and refinement of new therapies. Our mission is to accelerate meaningful progress and deliver better outcomes—today and for generations to come.

Our Vision

We envision a world where groundbreaking medical advancements lead to improved health outcomes, providing hope and innovative solutions to patients and communities globally.

Our Journey

The Story Behind Next Phase Research

Founded with a passion for improving patient lives, Next Phase Research has become a trailblazer in clinical trials. Our journey is marked by countless partnerships, innovative scientific explorations, and a steadfast commitment to transforming healthcare for the better.

Every trial and breakthrough we create reflects our dedication to patient welfare and medical advancement, guiding our mission to foster a healthier tomorrow.

Our areas of expertise

Comprehensive Clinical Research Solutions

  • Mental Health (CNS)
  • Gastroenterology / Hepatology
  • Vaccines
  • Psychedelic Work
  • Substance Abuse & Addiction
  • Women’s Health
  • Sleep Studies

Our Impact in Numbers

+
Over 1000 successful clinical trials completed, contributing to advancements in various medical fields.
%
A 100% of studies that met enrollment.

Join Us in Shaping Healthier Futures

Contact us today to explore clinical research opportunities and collaborations.

What Our Patients Say

Next Phase Research provided unparalleled support during my clinical trial, leading to life-changing treatments for my condition.

John Smith

I felt cared for and valued throughout the research process; my experience exceeded all expectations.

David Brown

Ready to Collaborate?

Connect with Us to Make a Difference

Join our mission to advance clinical research and improve healthcare outcomes through innovative partnerships and trials.

Scroll to Top